Novartis India Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Novartis India Limited with three other
companies in this sector in India:
Astrazeneca Pharma India Ltd
sales of 5.71 billion Indian Rupees [US$78.91 million]
Neuland Laboratories Limited
(5.27 billion Indian Rupees [US$72.89 million]
Caplin Point Laboratories Limited
(5.40 billion Indian Rupees [US$74.61 million]
of which 100%
Novartis India Limited reported sales of 5.64 billion Indian Rupees (US$77.93 million)
March of 2018.
decrease of 14.1%
versus 2017, when the company's sales were 6.56 billion Indian Rupees.